Treating Scleroderma by Targeting Pro-Fibrotic Macrophages: Highlighting Biomarkers of M2-like Macrophages-Levels in Systemic Sclerosis
Time: 12:00 pm
day: Day 1 - Stream B - Morning
Details:
- Highlighting macrophage activation states and the role of M2-like macrophages in fibrosis
- Exploring novel approaches to targeting this type of pathogenic cell
